Page last updated: 2024-11-04

sevoflurane and Depressive Disorder, Treatment-Resistant

sevoflurane has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Feng, M1
Cheng, S1
Fang, Y1
Lv, L1
Guo, P1
Wang, S1
Chen, H1

Other Studies

1 other study available for sevoflurane and Depressive Disorder, Treatment-Resistant

ArticleYear
Augmentation of Sevoflurane inhalation for treatment-resistant depression with different features: A case series.
    Asian journal of psychiatry, 2023, Volume: 82

    Topics: Antidepressive Agents; Antipsychotic Agents; Depression; Depressive Disorder, Treatment-Resistant; D

2023